科興生物8月29日(ri)宣布，該(gai)公(gong)(gong)司(si)(si)已(yi)獲悉一項Alternative Liquidity Index LP提出(chu)的部分(fen)要約(yue)收購(gou)，擬以每股(gu)(gu)(gu)0.03美元的價格收購(gou)最(zui)多(duo)1000萬股(gu)(gu)(gu)公(gong)(gong)司(si)(si)股(gu)(gu)(gu)份(fen)，約(yue)占已(yi)發(fa)行(xing)股(gu)(gu)(gu)份(fen)的10.05%。科興董(dong)(dong)事會(hui)(hui)打算(suan)評估要約(yue)收購(gou)的條(tiao)款，以確定其(qi)認為最(zui)符合公(gong)(gong)司(si)(si)及(ji)其(qi)股(gu)(gu)(gu)東最(zui)佳利益的行(xing)動(dong)方案，董(dong)(dong)事會(hui)(hui)打算(suan)在收到(dao)要約(yue)后(hou)10個工作(zuo)日(ri)內(nei)向(xiang)股(gu)(gu)(gu)東通(tong)報(bao)董(dong)(dong)事會(hui)(hui)對(dui)要約(yue)收購(gou)的立場，同(tong)時(shi)強烈建議(yi)公(gong)(gong)司(si)(si)股(gu)(gu)(gu)東不就要約(yue)收購(gou)采取(qu)任(ren)何行(xing)動(dong)。